David R. Bauer
Lawyers
Filters
TARGAN sale to Merck Animal Health
We are advising TARGAN on the transaction
IDEAYA Biosciences $345 million equity offering
We advised the joint book-running managers and underwriters on the offering
GSK $10.6 billion acquisition of Nuvalent
We are advising GSK on the transaction
Inventiva $120 million underwritten offering
We advised the underwriters on the offering
Sumitomo Pharma ¥102.1 billion stock offering
We advised the joint lead managers and joint bookrunners on the offering
Roche acquisition of SAGA Diagnostics
We advised Roche on the transaction
Editas Medicine $125 million follow-on offering
We advised the joint book-running managers on the offering
Immix Biopharma $150 million stock offering
We advised the lead bookrunner and the underwriters on the offering
Neptune $300 million follow-on offering
We advised the underwriters on the offering
Oruka Therapeutics collaboration with Halozyme
We advised Oruka Therapeutics on the transaction